Clinical trials for psychotropic medication typically involve an elaborate screening process, where patients are required to meet complex inclusion and…
Read MoreUsing Electronic Health Records to Recruit Patients with Mild Cognitive Impairment for Clinical Trials
Ana Todorovic, Sophie Gibbons, Philip Craig, Benjamin Fell IntroductionPsychotropic drug trials often involve a substantial period of patient recruitment. Psychiatrists…
Read MoreA data-driven approach to clinical trial patient samples
Names: Panagiota Kontari, Sophie Gibbons, Simon Pilinger, Elizabeth Ford, Benjamin Fell Background Using electronic health records (EHRs) as a source…
Read MorePatient and Public Involvement Co-Development of a Route to Record-Level Data Access to Akrivia Health’s Secondary Healthcare Dataset
Background: Oxford Mental Illness and Suicide tool (OxMIS) is a brief, scalable, freely available, structured risk assessment tool to assess suicide risk in…
Read MoreIdentifying Predictors of Suicide in Severe Mental Illness: A Feasibility Study of a Clinical Prediction Rule (Oxford Mental Illness and Suicide Tool or OxMIS)
Is Regulation A Barrier to Innovation? Yes. Undeniably, unequivocally, yes. That is not a particularly satisfying answer, is it? The…
Read MoreIs Regulation A Barrier to Innovation?
Findings from the Angela Project Neuropsychiatry and behavioural neurology/assessment/measurement of neuropsychiatric/behavioural and psychological symptoms Background The presentation of dementia in…
Read MoreThe status of current clinical practice in diagnosis of young onset dementia in England
Our approach to accelerating research is grounded in the principle of data protection by design and default. The technologies and…
Read MoreEnhancing mental health research with better context for clinical concepts within EHRs
As we know, medical records can cover a long history of diseases (as Akrivia Health has found up to ninety…
Read MoreWhy AI?
Natural Language Processing (NLP) is a form of Artificial Intelligence which processes language. Natural Language Processing (NLP) has existed for…
Read MoreWhat is Natural Language Processing (NLP)?
It is difficult to imagine the world of science without its laws dictating the need for clinical trials. Most probably…
Read MoreThe acceleration of clinical trials through the optimisation of Akrivia Health’s platform
It is probably true to say one of the most terrifying aspects of Alzheimer’s Disease (AD) is in its very…
Read MoreThe necessity of personalised data in precision medicine- A programme by Akrivia Health
Background: Major depressive disorder (MDD) is common and often has sub-optimal response to treatment. Difficult-to-treat depression (DTD) is a new…
Read MoreThe Burden associated with, and management of difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom
Introduction Akrivia Health works with a network of 16 mental healthcare organisations (the Akrivia Network) providing them with a service.…
Read MoreDCMS Data Reform Consultation Response
MHRA Consultation on Proposals for Legislative Changes to Clinical Trials Introduction Akrivia Health works with a network of 16 mental…
Read MoreMHRA Consultation Response
Abstract Background Donepezil, galantamine, rivastigmine and memantine are potentially effective interventions for cognitive impairment in dementia, but the use of…
Read MorePersonalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model
BACKGROUND Antipsychotic medications such as risperidone, olanzapine and aripiprazole are used to treat psychological and behavioural symptoms among dementia…
Read MoreAssociated mortality risk of atypical antipsychotic medication in individuals with dementia